• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢泊肟对社区获得性呼吸道感染病原体的体外活性。

In-vitro activity of cefpodoxime against pathogens responsible for community-acquired respiratory tract infections.

作者信息

Dabernat H, Avril J L, Boussougant Y

机构信息

Laboratoire de Microbiologie, Centre Hospitalier Universitaire Purpan, Toulouse, France.

出版信息

J Antimicrob Chemother. 1990 Dec;26 Suppl E:1-6. doi: 10.1093/jac/26.suppl_e.1.

DOI:10.1093/jac/26.suppl_e.1
PMID:2127267
Abstract

The in-vitro activity of cefpodoxime, the active compound of the ester prodrug, cefpodoxime proxetil, was compared with that of other antibiotics. The susceptibility of bacterial isolates from patients with respiratory tract infections was determined by an agar dilution method. The MIC90s of cefpodozime for ampicillin-sensitive and beta-lactamase-producing strains of Haemophilus influenzae were 0.12 and 0.25 mg/l, respectively; the MIC90s for ampicillin-resistant non-beta-lactamase-producing strains was 1 mg/l. Time-kill curves of cefpodoxime against ampicillin-sensitive and ampicillin-resistant beta-lactamase producing strains showed a time-dependent bactericidal activity. The MIC90s for ampicillin-sensitive and ampicillin-resistant Branhamella catarrhalis were 0.50 and 1 mg/l, respectively. The MIC90s for penicillin-sensitive pneumococci, beta-haemolytic streptococci and Streptococcus agalactiae were 0.06, 0.06 and 0.12 mg/l, respectively. The inhibitory activity against penicillin-resistant pneumococci was limited: the MIC90 was 4 mg/l.

摘要

将酯前体药物头孢泊肟酯的活性化合物头孢泊肟的体外活性与其他抗生素进行了比较。采用琼脂稀释法测定呼吸道感染患者分离菌株的敏感性。头孢泊肟对流感嗜血杆菌氨苄西林敏感菌株和产β-内酰胺酶菌株的MIC90分别为0.12和0.25mg/l;对氨苄西林耐药的非产β-内酰胺酶菌株的MIC90为1mg/l。头孢泊肟对氨苄西林敏感和氨苄西林耐药的产β-内酰胺酶菌株的时间-杀菌曲线显示出时间依赖性杀菌活性。头孢泊肟对氨苄西林敏感和氨苄西林耐药的卡他莫拉菌的MIC90分别为0.50和1mg/l。对青霉素敏感的肺炎球菌、β-溶血性链球菌和无乳链球菌的MIC90分别为0.06、0.06和0.12mg/l。对青霉素耐药肺炎球菌的抑制活性有限:MIC90为4mg/l。

相似文献

1
In-vitro activity of cefpodoxime against pathogens responsible for community-acquired respiratory tract infections.头孢泊肟对社区获得性呼吸道感染病原体的体外活性。
J Antimicrob Chemother. 1990 Dec;26 Suppl E:1-6. doi: 10.1093/jac/26.suppl_e.1.
2
In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.中国社区获得性呼吸道感染患者肺炎链球菌、流感嗜血杆菌和卡他莫拉菌的体外药物敏感性研究:头孢地尼及其他比较药物的活性
Diagn Microbiol Infect Dis. 2012 Jun;73(2):187-91. doi: 10.1016/j.diagmicrobio.2012.03.005. Epub 2012 Apr 21.
3
Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.加拿大流感嗜血杆菌、肺炎链球菌和卡他莫拉菌分离株的抗菌药敏性测定。加拿大抗菌研究小组。
J Antimicrob Chemother. 1999 Mar;43 Suppl A:25-30.
4
Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.对化脓性链球菌、肺炎链球菌、流感嗜血杆菌和卡他莫拉菌对14种口服抗生素耐药性的多中心监测。
J Formos Med Assoc. 2004 Sep;103(9):664-70.
5
[Comparative antibacterial activity of cefpodoxime against Haemophilus influenzae, Streptococcus pyogenes, Streptococcus pneumoniae and Moraxella catarrhalis].头孢泊肟对流感嗜血杆菌、化脓性链球菌、肺炎链球菌和卡他莫拉菌的抗菌活性比较
Arzneimittelforschung. 1994 May;44(5):668-70.
6
Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.新型广谱头孢菌素头孢托罗对流感嗜血杆菌和卡他莫拉菌的活性。
Antimicrob Agents Chemother. 2006 Jun;50(6):2050-7. doi: 10.1128/AAC.00044-06.
7
Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States.头孢妥仑对2004 - 2006年美国社区获得性呼吸道感染相关的流感嗜血杆菌和卡他莫拉菌当代分离株的抗菌活性。
Diagn Microbiol Infect Dis. 2008 Jun;61(2):240-4. doi: 10.1016/j.diagmicrobio.2008.01.015. Epub 2008 Mar 19.
8
[Serotype distribution and drug resistance of , and isolated from nasopharynx of Uygur children].[从维吾尔族儿童鼻咽部分离出的、和的血清型分布及耐药性]
Zhonghua Er Ke Za Zhi. 2018 Apr 2;56(4):279-283. doi: 10.3760/cma.j.issn.0578-1310.2018.04.008.
9
In vitro activity of cefpodoxime in comparison with other oral beta-lactam antibiotics.头孢泊肟与其他口服β-内酰胺类抗生素相比的体外活性。
Infection. 1994 Sep-Oct;22(5):370-5. doi: 10.1007/BF01715556.
10
[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].[2009年至2010年期间从中国成年人中分离出的社区获得性呼吸道病原体的抗菌药敏性]
Zhonghua Jie He He Hu Xi Za Zhi. 2012 Feb;35(2):113-9.

引用本文的文献

1
[Current management of acute pediatric rhinosinusitis in France].[法国儿童急性鼻窦炎的当前管理]
Med Mal Infect. 2007 Mar;37(3):127-52. doi: 10.1016/j.medmal.2006.11.008. Epub 2007 Feb 21.
2
Moraxella catarrhalis: from emerging to established pathogen.卡他莫拉菌:从新兴病原体到既定病原体。
Clin Microbiol Rev. 2002 Jan;15(1):125-44. doi: 10.1128/CMR.15.1.125-144.2002.
3
Cephalosporin utilisation review and evaluation.头孢菌素使用情况回顾与评估
Pharmacoeconomics. 1995 Aug;8(2):100-22. doi: 10.2165/00019053-199508020-00003.
4
Activity of once-daily cefpodoxime regimens against Haemophilus influenzae and Streptococcus pneumoniae with an in vitro pharmacodynamic chamber model.采用体外药效学腔室模型研究每日一次头孢泊肟治疗方案对流感嗜血杆菌和肺炎链球菌的活性。
Antimicrob Agents Chemother. 1996 Jun;40(6):1545-7. doi: 10.1128/AAC.40.6.1545.
5
Oral cephalosporins for use in a parenteral-to-oral switch programme.用于肠外转口服转换方案的口服头孢菌素。
Infection. 1995;23 Suppl 2:S87-90. doi: 10.1007/BF01742991.
6
Cefpodoxime proxetil in the treatment of lower respiratory tract infections.头孢泊肟酯治疗下呼吸道感染
Drugs. 1991;42 Suppl 3:34-40. doi: 10.2165/00003495-199100423-00008.
7
Cefpodoxime proxetil in upper respiratory tract infections.头孢泊肟酯在上呼吸道感染中的应用
Drugs. 1991;42 Suppl 3:25-33. doi: 10.2165/00003495-199100423-00007.
8
Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.头孢泊肟酯。对其抗菌活性、药代动力学特性及治疗潜力的综述。
Drugs. 1992 Nov;44(5):889-917. doi: 10.2165/00003495-199244050-00011.